Skip Navigation

European Heart Journal 2003 24(21):1899-1900; doi:10.1016/j.ehj.2003.08.012
Copyright © 2003 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hennekens, C. H
Right arrow Articles by D'Agostino, R. B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hennekens, C. H
Right arrow Articles by D'Agostino, R. B
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

Global risk assessment for cardiovascular disease and astute clinical judgement

Charles H Hennekensa,* and Ralph B D'Agostinob

a University of Miami School of Medicine, Miami, USA
b Boston University, Boston, USA

* Correspondence to: Dr C. H. Hennekens, 4300 Alton Road, Suite 207A, Miami Beach, Florida 33140, USA. Tel: +1 561 393-8845; fax: +1 561 393-8845
E-mail address: PROFCHHMD@prodigy.net

Received 22 August 2003; accepted 28 August 2003

The first 10% of the full text of this article appears below.

See doi:10.1016/j.ehj.2003.09.002 for the article to which this editorial refers

In their thoughtful and provocative article ‘Are the Framingham and PROCAM coronary heart disease riskfunctions applicable to different European populations? The PRIME Study’, Drs Empana and colleagues astutely conclude that the answer is neither simple nor straightforward.1On the one hand, they conclude that the Framingham (from the United States) and PROCAM (from Germany) risk functions overestimated the absolute risk of coronary heart disease in middle . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations?: The PRIME Study
J.P Empana, P Ducimetière, D Arveiler, J Ferrières, A Evans, J.B Ruidavets, B Haas, J Yarnell, A Bingham, P Amouyel, J Dallongeville, and on behalf of the PRIME Study Group
EHJ 2003 24: 1903-1911. [Abstract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
M. T. Cooney, A. L. Dudina, and I. M. Graham
Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.
J. Am. Coll. Cardiol., September 29, 2009; 54(14): 1209 - 1227.
[Abstract] [Full Text] [PDF]

Home page
 Int J EpidemiolHome page
H.-W. Hense
Observations, predictions and decisions--assessing cardiovascular risk assessment
Int. J. Epidemiol., April 1, 2004; 33(2): 235 - 239.
[Full Text] [PDF]